News
On this week's episode of "The Readout LOUD": a closer look at the NIH’s grant-cutting legal playbook, FDA transparency ...
The FDA has released an “initial batch“ of more than 200 complete response letters (CRLs) in efforts to boost transparency. | ...
The US Food and Drug Administration has started making rejection letters that pharmaceutical companies traditionally keep ...
2don MSN
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...
The FDA’s clunky launch of Elsa, an AI tool to increase efficiency, has sparked concern from agency employees and outside ...
FDA to "review the latest data" on mifepristone. What could it mean for access to the abortion pill?
HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone," but experts say concerns ...
Warnings about withdrawal from antidepressants have rippled through society in recent years. A new study claims they are ...
FDA to issue new vaccine approval guidance amid questions over coronavirus shots FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming ...
FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.
Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or whether they should be recommended only for people at increased risk.
Meijer Inc. announced a recall of thousands of cases of Frederik's Dark Chocolate Almonds on June 13 due to the possible ...
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results